XML 206 R47.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders' Equity (Details) - $ / shares
3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2023
Jun. 30, 2025
Dec. 31, 2022
Dec. 31, 2020
Apr. 04, 2025
Dec. 31, 2024
Sale of Stock [Line Items]            
Common stock, authorized (in shares)   200,000,000       200,000,000
Common stock, par value (usd per share)   $ 0.00001       $ 0.00001
Common stock, issued (in shares)   73,819,710       72,720,866
Common stock, outstanding (in shares)   73,819,710       72,720,866
Preferred stock, authorized (in shares)   10,000,000       10,000,000
Preferred stock, par value (usd per share)   $ 0.00001       $ 0.00001
Preferred stock, issued (in shares)   0       0
Remaining unvested warrant shares (in shares)   3,170,834     3,170,834  
Omnibus Agreement            
Sale of Stock [Line Items]            
Class of warrant common stock exercise price (usd per share)     $ 0.01      
Vesting period 5 years          
Omnibus Agreement | Warrant shares            
Sale of Stock [Line Items]            
Warrant, number of shares issuable, common stock (in shares)     3,352,025      
Vesting period   5 years 5 years      
Affiliated entity | The Lemonade Foundation | Lemonade, Inc.            
Sale of Stock [Line Items]            
Shares owned by foundation (in shares)   400,000       400,000
The Lemonade Foundation | Affiliated entity            
Sale of Stock [Line Items]            
Contribution to the Lemonade Foundation (in shares)   500,000   500,000